Metastatic Cancer Tr

iCrowdNewswire   Jan 27, 2021  2:00 AM ET

The global metastatic cancer treatment market is projected to be worth USD 111.16 Billion by 2027, according to a current analysis by Emergen Research.

The increasing incidence of metastatic cancer is one of the significant factors influencing the market growth.

The metastatic cancer treatment systems market is observing high demand attributed to the increasing incidence of cancer. The disease significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.

Growing technological advancements and increased investments in imaging technologies are causative of the rapid growth of the metastatic cancer treatment market. Hologic, Inc., in November 2019, received approval from the US Food and Drug Administration (FDA) for its 3DQuorum™ Imaging Technology, driven by Genius AI™. The technology works simultaneously with Hologic’s Clarity HD™ high-resolution imaging technology and helps radiologists reduce tomosynthesis image volume by 66.0%.

Get a Sample of the report @ https://www.emergenresearch.com/request-sample-form/329

The key manufacturers profiled in the report are Bayer AG, Johnson & Johnson, AstraZeneca PLC, Pfizer Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Amgen Inc., Merck & Co. Inc., AbbVie Inc., and Novartis AG, among others. The report further offers insights into the strategic initiatives taken by the companies such as mergers & acquisitions, brand promotions, and product launches, technological advancements, product developments, advancements in the research and development sector, and government deals and funding.

  • Treatment Type Outlook (Revenue, USD Billion; 2017-2027)
    • Chemotherapy
    • Hormone Therapy
    • Immunotherapy
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Breast Cancer
    • Lung Cancer
    • Melanoma
    • Prostate Cancer
    • Colorectal Cancer
    • Others
  • End Users Outlook (Revenue, USD Billion; 2017-2027)
    • Hospital
    • Clinics
    • Research Institutes
    • Others

For a detailed understanding of the competitive landscape, a thorough regional analysis covering North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, is offered in the report. It studies the market size, market share, revenue contribution, production and consumption patterns, supply and demand ratio, import/export, and the operations of the key players operating in those regions. Furthermore, the report also covers a country-wise analysis of the industry.

Request a Discount on the Report @ https://www.emergenresearch.com/request-discount-form/329

The metastatic cancer treatment market in the North American region held the largest market share in 2019, owing to the high adoption of advanced treatment technologies, a rising incidence of cancer, established healthcare infrastructure, and undertaking of various initiatives to create awareness about the disease.

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Metastatic Cancer Treatment Market Segmentation & Impact Analysis

    4.1. Metastatic Cancer Treatment Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Increasing incidence of cancer

                    4.2.2.2. Rising government initiatives to spread cancer awareness

                    4.2.2.3. Increase in healthcare expenditure

                    4.2.2.4. Growing geriatric population

          4.2.3. Market restraints analysis

                    4.2.3.1. Cost-prohibitive treatment

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Chapter 5. Metastatic Cancer Treatment Market By Treatment Type Insights & Trends, Revenue (USD Million)

    5.1. Treatment Type Dynamics & Market Share, 2019 & 2027

          5.1.1. Chemotherapy

          5.1.2. Hormone Therapy

          5.1.3. Immunotherapy

          5.1.4. Others

Chapter 6. Metastatic Cancer Treatment Market By Application Insights & Trends Revenue (USD Million)

    6.1. Application Dynamics & Market Share, 2019 & 2027

          6.1.1. Breast Cancer

          6.1.2. Lung Cancer

          6.1.3. Melanoma

          6.1.4. Prostate Cancer

          6.1.5. Colorectal Cancer

          6.1.6. Others

Continue…!

Request for Customization on the Report @ https://www.emergenresearch.com/request-for-customization-form/329

Thank you for reading our report. The report can be customized based on regional segmentation and competitive landscape. Kindly get in touch with us to know more, and our team will ensure the report is well suited to meet your requirements.

Contact Information:

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs


iCrowdNewswire

Keywords:    Metastatic Cancer Treatment Market, Metastatic Cancer Treatment Market 2021, Metastatic Cancer Treatment Market Size, Metastatic Cancer Treatment Market Share, Metastatic Cancer Treatment Market Demand, Metastatic Cancer Treatment Market types, Metastatic Cancer Treatment Market forecast, Metastatic Cancer Treatment Market Growth